Methotrexate Withdrawn Phase 1 Trials for Rheumatoid Arthritis Basic Science

IndicationsStatusPurposePhase
WithdrawnBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT00920608A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients